Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Takeda Launches Diabetes Drugs
Zacks
Saturday, June 22, 2013 - 10:44am
tags:
Takeda, Nesina, Kazano, Oseni
Recalls: Medtronic pulls Trivantage tracheal tube, Paradigm and Polyfin insulin pumps
Mass Device
Saturday, June 22, 2013 - 10:43am
tags:
Medtronic, devices, recall, paradigm spine
Philips' Respironics hit with yet another ventilator recall
FierceMedicalDevice
Saturday, June 22, 2013 - 10:41am
tags:
Phillips, ventilator, recall, devices
Takeda files BLA for vedolizumab for Crohn's and ulcerative colitis in USA
The Pharma Letter
Saturday, June 22, 2013 - 10:38am
tags:
Takeda, vedolizumab, Chron's Disease, ulcerative colitis
France ponies up for study of GI Dynamics' obesity tech
FierceMedicalDevice
Saturday, June 22, 2013 - 10:36am
tags:
France, GI Dynamics, obesity, devices
J&J's Animas reveals positive artificial pancreas data
FierceMedicalDevice
Saturday, June 22, 2013 - 10:35am
tags:
J&J, artificial pancreas, clinical trials, devices
Illumina's Gene-Analysis Systems Key To Medical Research
investors.com
Saturday, June 22, 2013 - 10:31am
tags:
Illumina, genetic technologies
Solta Medical receives FDA clearance for skin pigmentation treatment
The Fly On The Wall
Saturday, June 22, 2013 - 10:31am
tags:
Solta Medical, FDA, regulatory, devices, skin, treatment
Medtronic announces 80M share repurchase plan
Yahoo/TheFlyOnTheWall
Saturday, June 22, 2013 - 10:30am
tags:
Medtronic, stock, share repurchase, stock buyback, devices
Jay Shreiner Joins NxStage Board of Directors
Yahoo/PRNewswire
Saturday, June 22, 2013 - 10:29am
tags:
NxStage Medical, Management, devices
U.S. Center Adopts ARAY's CyberKnife
Yahoo/Zacks
Saturday, June 22, 2013 - 10:28am
tags:
Cyberknife, Accuray, devices
J&J’s Pump Automatically Adjusts Insulin for Diabetics
Bloomberg
Saturday, June 22, 2013 - 10:27am
tags:
J&J, insulin pump, devices, diabetics, diabetes
Theravance Announces FDA Approval of VIBATIV(R) (telavancin) for the Treatment of Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia
Yahoo/Market Wired
Saturday, June 22, 2013 - 10:25am
tags:
Theravance, Vibativ, hospital-acquired bacterial pneumonia, pneumonia
Regeneron Pharmaceuticals Inc. (REGN): Today's Featured Drugs Laggard
The Street
Saturday, June 22, 2013 - 10:23am
tags:
Regeneron
Amgen Inc (AMGN): Today's Featured Health Care Winner
The Street
Saturday, June 22, 2013 - 10:22am
tags:
Amgen
CLOTS 3 Study Delivers Lifesaving Results Using Covidien’s Blood Clot Prevention Technology
Yahoo/BusinessWire
Saturday, June 22, 2013 - 10:21am
tags:
Covidien, blood clots, devices
Nanosphere Appoints Gene Cartwright, Ph.D. and Erik Holmlin, Ph.D. to its Board of Directors
Yahoo/AccessWire
Saturday, June 22, 2013 - 10:20am
tags:
Nanosphere, devices, Management
Cantel Medical Board Of Directors Announces 3-for-2 Stock Split And Authorizes Regular Semiannual Dividend
Yahoo/PRNewswire
Saturday, June 22, 2013 - 10:19am
tags:
Cantel Medical, Management, devices, stock
Anika Therapeutics: Profitable, Cheap And Overlooked
Seeking Alpha
Saturday, June 22, 2013 - 10:19am
tags:
Anika
Raptor Pharma's Procysbi Launched in the US
Yahoo/Zacks
Saturday, June 22, 2013 - 10:14am
tags:
Raptor Pharmaceuticals, procysbi, nephropathic cystinosis

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.